Wuhan Jianmin Pharmaceutical Group
Wuhan Jianmin Pharmaceutical engages in the research and development, production, and sale of pharmaceuticals primarily in China.
Launch date
Employees
Market cap
AUD1.3b
Enterprise valuation
AUD1.2b (Public information from Sep 2024)
Share price
CNY41.65 600976.SS
Wuhan Hubei (HQ)
Authorizing premium user...